These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10968396)
1. Test and teach. Number One hundred and four. Mu heavy chain disease (mu-HCD). Campbell JK; Juneja SK Pathology; 2000 Aug; 32(3):202-3; 227. PubMed ID: 10968396 [No Abstract] [Full Text] [Related]
2. The pathology of gamma heavy chain disease: report of a case with morphologic progression from lymphocytic to plasmacytic proliferation. Marsh WL; Worthman JW; Spiegelberg HL Cancer; 1981 Jun; 47(12):2878-82. PubMed ID: 6790158 [No Abstract] [Full Text] [Related]
3. Detection and preparation of immunoglobulin (Ig) mu chain protein in sera of patients with heavy chain diseases (HCD). Wetter O; Drosdziok W; Müller B Klin Wochenschr; 1975 Sep; 53(18):885-6. PubMed ID: 809615 [TBL] [Abstract][Full Text] [Related]
4. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion. Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850 [TBL] [Abstract][Full Text] [Related]
5. Mu-heavy chain disease associated with systemic amyloidosis. Kinoshita K; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M; Kanamaru A Hematology; 2004 Apr; 9(2):135-7. PubMed ID: 15203869 [TBL] [Abstract][Full Text] [Related]
6. The histopathology of gamma heavy-chain disease. Wester SM; Banks PM; Li CY Am J Clin Pathol; 1982 Oct; 78(4):427-36. PubMed ID: 6814232 [No Abstract] [Full Text] [Related]
12. Rheumatoid arthritis terminating in heavy-chain disease. Zawadzki ZA; Benedek TG; Ein D; Easton JM Ann Intern Med; 1969 Feb; 70(2):335-47. PubMed ID: 4179297 [No Abstract] [Full Text] [Related]
13. Gamma heavy chain disease and giant lymph node hyperplasia in a patient with impaired T cell function. Okuda K; Himeno Y; Toyama T; Ohta M; Kitagawa M; Sugai S Jpn J Med; 1982 Apr; 21(2):109-14. PubMed ID: 6811785 [No Abstract] [Full Text] [Related]
14. Heavy chain diseases: current findings and concepts. Seligmann M; Mihaesco E; Preud'homme JL; Danon F; Brouet JC Immunol Rev; 1979; 48():145-67. PubMed ID: 121099 [No Abstract] [Full Text] [Related]
15. Morphologic features of μ-heavy-chain disease. Courtois L; Sujobert P Blood; 2017 Jul; 130(4):558. PubMed ID: 28751360 [No Abstract] [Full Text] [Related]
16. The defect in mu heavy chain disease protein GLI. Franklin EC; Frangione B; Prelli F J Immunol; 1976 Apr; 116(4):1194-5. PubMed ID: 815437 [TBL] [Abstract][Full Text] [Related]
17. gamma- and mu-Heavy chain diseases and related disorders. Franklin EC J Clin Pathol Suppl (Assoc Clin Pathol); 1975; 6():65-71. PubMed ID: 830056 [No Abstract] [Full Text] [Related]
18. [Clinicopathological studies of heavy chain diseases]. Imamura Y Nihon Rinsho; 1977 Apr; 35(4):1653-61. PubMed ID: 407384 [No Abstract] [Full Text] [Related]
19. Gamma heavy chain disease. Reports of three patients. Westin J; Eyrich R; Falsen E; Lindholm L; Lundin P; Lönnroth I; Weinfeld A Acta Med Scand; 1972 Oct; 192(4):281-92. PubMed ID: 4562896 [No Abstract] [Full Text] [Related]
20. Mu heavy-chain disease--a defect in immunoglobulin assembly. Structural studies of the kappa chain. Frangione B; Franklin EC; Prelli F Scand J Immunol; 1976; 5(6-7):623-7. PubMed ID: 824712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]